If you’re an AP Computer Science student using CodeHS, you’re about to get a significant upgrade: the platform is refreshing its Python curriculum for Fall 2026 with improved autograders, clearer ...

Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter ...

With Flash GA, the company is attempting to transition from being a provider of raw compute to becoming the essential ...

There appears to be a recent epidemic of users hijacking companies’ AI-powered customer service bots to turn them into ...

NEW DELHI: A wave of affordable generic versions of Ozempic and Wegovy (semaglutide) has rapidly captured around 20% of the nearly Rs 1,600 crore weight-loss market within days of launch, following ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

Multiple dapagliflozin generic approvals are expected to intensify near-term market competition, requiring manufacturers to coordinate production readiness, launch timing, and labeling compliance ...

The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...

Patients in Canada have been paying between $300 and $400 a month for Ozempic and Wegovy, depending on the prescribed dose You can save this article by registering for free here. Or sign-in if you ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

The approval is expected to offer more affordable treatment options and potentially reduce asthma-related complications nationwide. The FDA has authorized the first generic version of fluticasone ...